
NYSE:GS
This summary was created by AI, based on 27 opinions in the last 12 months.
Goldman Sachs (GS) has received overwhelmingly positive reviews from experts, particularly following a spectacular earnings report that contributed to the stock's rise, marking a new all-time high. The firm has been successful in capturing significant capital and interest, mainly due to activities in the IPO and M&A sectors, for which it has been identified as a leading player. Additionally, GS recently raised its dividend by 11%, reflecting strong financial health and a solid betting ground for investors looking for income amidst inflation. While some analysts express caution regarding GS's exposure to private credit markets and a potential slowdown in growth relative to previous years, the overall sentiment indicates a robust outlook for the company's ongoing performance in investment banking, capital markets, and wealth management, with high expectations for future earnings. With a strong track record and favorable market conditions, GS remains a critical player in the financial landscape, although some experts prefer other options tied to secular growth trends.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Goldman Sachs is a American stock, trading under the symbol GS (previously GS-N on Stockchase) on the New York Stock Exchange (GS). It is usually referred to as NYSE:GS or GS
In the last year, 28 stock analysts issued a Buy, Sell, or Hold rating on GS (previously GS-N on Stockchase). 22 analysts recommended to BUY and 3 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Goldman Sachs.
Goldman Sachs was recommended as a Top Pick by Colin Cieszynski on 2026-07-15. Read the latest stock experts ratings for Goldman Sachs.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Goldman Sachs.
Goldman Sachs is followed by 229 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-20, Goldman Sachs (GS) stock closed at a price of $1,058.51.
Absolutely spectacular earnings. Up 7% today off its earnings report, one of the best moves we've seen this season. Major breakout, new all-time high. Attracting capital, attracting interest. Rapidly climbing within his RSI universe. Yield is 1.75%.
(Analysts’ price target is $1109.73)